Peggy Wallace - Net Worth and Insider Trading

Peggy Wallace Net Worth

The estimated net worth of Peggy Wallace is at least $19,170 dollars as of 2024-11-10. Peggy Wallace is the Director of Cognition Therapeutics Inc and owns about 37,961 shares of Cognition Therapeutics Inc (CGTX) stock worth over $19,170. Details can be seen in Peggy Wallace's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peggy Wallace has not made any transactions after 2022-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peggy Wallace

To

Peggy Wallace Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peggy Wallace owns 1 companies in total, including Cognition Therapeutics Inc (CGTX) .

Click here to see the complete history of Peggy Wallace’s form 4 insider trades.

Insider Ownership Summary of Peggy Wallace

Ticker Comapny Transaction Date Type of Owner
CGTX Cognition Therapeutics Inc 2022-11-15 director

Peggy Wallace Latest Holdings Summary

Peggy Wallace currently owns a total of 1 stock. Peggy Wallace owns 37,961 shares of Cognition Therapeutics Inc (CGTX) as of November 15, 2022, with a value of $19,170.

Latest Holdings of Peggy Wallace

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGTX Cognition Therapeutics Inc 2022-11-15 37,961 0.51 19,170

Holding Weightings of Peggy Wallace


Peggy Wallace Form 4 Trading Tracker

According to the SEC Form 4 filings, Peggy Wallace has made a total of 2 transactions in Cognition Therapeutics Inc (CGTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cognition Therapeutics Inc is the acquisition of 12,500 shares on November 15, 2022, which cost Peggy Wallace around $15,000.

Insider Trading History of Peggy Wallace

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peggy Wallace Trading Performance

GuruFocus tracks the stock performance after each of Peggy Wallace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peggy Wallace is -9%. GuruFocus also compares Peggy Wallace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peggy Wallace within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peggy Wallace's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peggy Wallace

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 36.01 LIMIT LIMIT LIMIT LIMIT LIMIT

Peggy Wallace Ownership Network

Ownership Network List of Peggy Wallace

No Data

Ownership Network Relation of Peggy Wallace

Insider Network Chart

Peggy Wallace Owned Company Details

What does Cognition Therapeutics Inc do?

Who are the key executives at Cognition Therapeutics Inc?

Peggy Wallace is the director of Cognition Therapeutics Inc. Other key executives at Cognition Therapeutics Inc include director & CEO & President Lisa Ricciardi , Chief Financial Officer John Brendan Doyle , and Chief Medical Officer Anthony Caggiano .

Cognition Therapeutics Inc (CGTX) Insider Trades Summary

Over the past 18 months, Peggy Wallace made no insider transaction in Cognition Therapeutics Inc (CGTX). Other recent insider transactions involving Cognition Therapeutics Inc (CGTX) include a net purchase of 5,700 shares made by Lisa Ricciardi ,

In summary, during the past 3 months, insiders sold 0 shares of Cognition Therapeutics Inc (CGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cognition Therapeutics Inc (CGTX) were sold and 5,700 shares were bought by its insiders, resulting in a net purchase of 5,700 shares.

Cognition Therapeutics Inc (CGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cognition Therapeutics Inc Insider Transactions

No Available Data

Peggy Wallace Mailing Address

Above is the net worth, insider trading, and ownership report for Peggy Wallace. You might contact Peggy Wallace via mailing address: C/o Cognition Therapeutics, Inc., 2500 Westchester Ave., Purchase Ny 10577.